Nonetheless, the mechanism underlying the activation of one TMM over another still remains to be clearly elucidated, even if a genetic basis (e.g., TERT promoter mutations, ATRX mutations, telomeric variant repeats) for the activation of either mechanism in cancer is becoming recognized [55]. Here, TERT is linked to cancer.